Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Celgene
Celgene
Up-and-coming Pfizer, AbbVie drugs set to threaten Amgen, Celgene: analyst
Fierce Pharma
Wed, 05/23/18 - 09:54 am
Pfizer
Xeljanz
AbbVie
Upadacitinib
JAK inhibitors
Amgen
Enbrel
Celgene
Celgene, stricken by setbacks, bids a quiet goodbye to dealmaking czar Golumbeski
Fierce Pharma
Mon, 05/21/18 - 10:05 pm
Celgene
George Golumbeski
FDA calls out 39 drug companies for allegedly blocking access to generics
Stat
Thu, 05/17/18 - 10:15 am
JNJ
Actelion
Celgene
Gilead
Novartis
Pfizer
Valeant Pharmaceuticals
generics
FDA
Celgene Starts the Year With a Bang
Motley Fool
Mon, 05/14/18 - 11:03 pm
Celgene
earnings
Ex-Receptos CTO co-founds SD startup Escient, launching with $40M Series A
Endpoints
Wed, 05/9/18 - 09:35 pm
Receptos
Celgene
Marcus Boehm
Escient
G-protein coupled receptors
Who do you trust? For doctors, it's Bristol Myers-Squibb and Biogen
Fierce Pharma
Wed, 05/9/18 - 09:25 am
physicians
digital marketing
Bristol-Myers Squibb
Biogen
Celgene
Celgene's timeline for refiling ozanimod gets mixed reviews
Biopharma Dive
Sat, 05/5/18 - 10:58 am
Celgene
ozanimod
MS
multiple sclerosis
FDA
Celgene Rises As Q1 Earnings, Sales Top Views
Investors Business Daily
Fri, 05/4/18 - 10:09 am
Celgene
earnings
Earnings Preview: What To Expect From Celgene On Friday
Forbes
Thu, 05/3/18 - 11:04 pm
Celgene
earnings
4 Huge Pharma Deals in 4 Months Is Just the Beginning
Motley Fool
Sat, 04/28/18 - 12:18 pm
M&A
Takeda
Shire
Novartis
AveXis
Sanofi
Bioverativ
Celgene
Juno Therapeutics
A metabolite will make or break Celgene's ozanimod
Biopharma Dive
Sat, 04/28/18 - 11:53 am
Celgene
ozanimod
MS
multiple sclerosis
metabolite
Immunotherapies, biosimilars to dominate next week of earnings
Biopharma Dive
Tue, 04/24/18 - 10:50 pm
AbbVie
AstraZeneca
Bristol-Myers Squibb
Celgene
Roche
Vertex Pharmaceuticals
Sanofi
earnings
Celgene's Ozanimod Reduces Relapses and Brain Volume Loss in MS Patients in Phase III Trials
CP Wire
Tue, 04/24/18 - 10:31 am
Celgene
ozanimod
relapsing multiple sclerosis
MS
2 Beta Thalassemia Drugs Are Fast Approaching the Finish Line
Motley Fool
Sun, 04/22/18 - 11:52 am
Celgene
Bluebird Bio
beta thalassemia
LentiGlobin
luspatercept
Pfizer's Deal Potential Doesn't Stop at Bristol-Myers
Bloomberg
Fri, 04/13/18 - 08:52 am
Pfizer
M&A
Bristol-Myers Squibb
Celgene
Eli Lilly
AstraZeneca
Celgene on biotech hunt with Agios, Jounce in crosshairs: FT
Fierce Biotech
Mon, 04/9/18 - 10:33 am
Celgene
M&A
Agios Pharmaceuticals
Jounce Therapeutics
Celgene, AbbVie extracted higher prices in Q4 as other pharmas netted less: report
Fierce Pharma
Tue, 04/3/18 - 10:55 pm
Celgene
AbbVie
drug pricing
Celgene Parts with COO Scott Smith “Effective Immediately”
Xconomy
Tue, 04/3/18 - 09:13 am
Celgene
Scott Smith
Celgene, bluebird revise deal to co-develop CAR-T therapy
Biopharma Dive
Thu, 03/29/18 - 11:33 am
Celgene
Bluebird Bio
drug development
CAR-T
bb2121
Multiple Myeloma
Arena Pharmaceuticals Takes Aim at Celgene
Motley Fool
Fri, 03/23/18 - 09:35 pm
Arena Pharmaceuticals
Celgene
etrasimod
ozanimod
ulcerative colitis
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »